×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

GSK India posts 7.63% growth in Sep quarter

GSK India posts 7.63% growth in Sep quarter
Comment E-mail Print Share
First Published: Fri, Oct 30 2009. 11 39 PM IST
Updated: Fri, Oct 30 2009. 11 39 PM IST
Mumbai: The Indian listed subsidiary of British drug maker GlaxoSmithKline Plc, GlaxoSmithKline Pharmaceuticals Ltd (GSK Ltd), posted 7.63% growth in net profit at Rs141.08 crore during July-September quarter, as against the net profit of Rs131.97 crore in the year-ago quarter. The company’s sales during the period grew 12% at Rs522.68 crore compared with Rs478.84 crore.
The company, in a statement to stock exchanges, said the growth in total sales was impacted due to lower selling prices as a result of excise duty reduction being passed on to the customer.
Comment E-mail Print Share
First Published: Fri, Oct 30 2009. 11 39 PM IST
More Topics: Company Results | GSK India | Drugs | Pharma | Earnings |